213 related articles for article (PubMed ID: 34716470)
21. A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System.
Ferrucci PF; Cocorocchio E; Bonomo G; Varano GM; Della Vigna P; Orsi F
Cells; 2021 Jan; 10(1):. PubMed ID: 33466278
[TBL] [Abstract][Full Text] [Related]
22. Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
de Leede EM; Burgmans MC; Meijer TS; Martini CH; Tijl FGJ; Vuyk J; van Erkel AR; van der Velde CJH; Kapiteijn E; Vahrmeijer AL
Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1196-1205. PubMed ID: 28451811
[TBL] [Abstract][Full Text] [Related]
23. Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma.
Modi S; Gibson T; Vigneswaran G; Patel S; Wheater M; Karydis I; Gupta S; Takhar A; Pearce N; Ottensmeier C; Stedman B
Melanoma Res; 2022 Apr; 32(2):103-111. PubMed ID: 35254333
[TBL] [Abstract][Full Text] [Related]
24. Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.
Carr MJ; Sun J; Cohen JB; Liu J; Serdiuk AA; Stewart SR; Doobay N; Duclos A; Seal DA; Choi J; Zager JS
Cancer Control; 2020; 27(1):1073274820983019. PubMed ID: 33372814
[TBL] [Abstract][Full Text] [Related]
25. Selective Internal Radiotherapy (SIRT) and Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) for Metastasized Uveal Melanoma: A Retrospective Comparative Study.
Kolb M; Forschner A; Artzner C; Grözinger G; Said I; Dittmann H; Seith F
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894309
[TBL] [Abstract][Full Text] [Related]
26. Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
Hughes MS; Zager J; Faries M; Alexander HR; Royal RE; Wood B; Choi J; McCluskey K; Whitman E; Agarwala S; Siskin G; Nutting C; Toomey MA; Webb C; Beresnev T; Pingpank JF
Ann Surg Oncol; 2016 Apr; 23(4):1309-19. PubMed ID: 26597368
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study.
Vogl TJ; Koch SA; Lotz G; Gebauer B; Willinek W; Engelke C; Brüning R; Zeile M; Wacker F; Vogel A; Radeleff B; Scholtz JE
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):864-872. PubMed ID: 28144756
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
Meijer TS; Dieters JHN; de Leede EM; de Geus-Oei LF; Vuijk J; Martini CH; van Erkel AR; Lutjeboer J; van der Meer RW; Tijl FGJ; Kapiteijn E; Vahrmeijer AL; Burgmans MC
PLoS One; 2022; 17(1):e0261939. PubMed ID: 35025911
[TBL] [Abstract][Full Text] [Related]
29. Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.
Meijer TS; Geus-Oei LF; Martini CH; Tijl FGJ; Sitsen ME; Erkel ARV; Meer RWV; Kapiteijn E; Vahrmeijer AL; Burgmans MC
Diagn Interv Radiol; 2019 Nov; 25(6):451-458. PubMed ID: 31650973
[TBL] [Abstract][Full Text] [Related]
30. Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma.
Chandrasekhar S; Perez M; Niaz Z; Ekram J; Lal N; Koly S; Cao B; Zager JS; Alomar M
Cancer Control; 2024; 31():10732748241246898. PubMed ID: 38605434
[TBL] [Abstract][Full Text] [Related]
31. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience.
Forster MR; Rashid OM; Perez MC; Choi J; Chaudhry T; Zager JS
J Surg Oncol; 2014 Apr; 109(5):434-9. PubMed ID: 24249545
[TBL] [Abstract][Full Text] [Related]
32. [Isolated liver perfusion with melphalan followed by pembrolizumab therapy for unresectable metastases of uveal melanoma to the liver].
Kaprin AD; Ivanov SA; Unguryan VM; Kazantsev AN; Belov YV
Khirurgiia (Mosk); 2023; (7):94-99. PubMed ID: 37379411
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.
Burgmans MC; de Leede EM; Martini CH; Kapiteijn E; Vahrmeijer AL; van Erkel AR
Cardiovasc Intervent Radiol; 2016 Jun; 39(6):801-14. PubMed ID: 26718962
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience.
Dewald CLA; Warnke MM; Brüning R; Schneider MA; Wohlmuth P; Hinrichs JB; Saborowski A; Vogel A; Wacker FK
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008282
[TBL] [Abstract][Full Text] [Related]
35. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
[TBL] [Abstract][Full Text] [Related]
36. ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma.
Meijer TS; Burgmans MC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):820-821. PubMed ID: 32683632
[No Abstract] [Full Text] [Related]
37. Initiation of Chemosaturation With Percutaneous Hepatic Perfusion Program in Interventional Radiology Department.
Öcal O; Eldem G; Karagoz AH; Kılıçkap S; Yalcin S; Balkanci F; Peynircioglu B
Cureus; 2021 Sep; 13(9):e17880. PubMed ID: 34660079
[TBL] [Abstract][Full Text] [Related]
38. Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Hofmann H; von Haken R; Werner J; Kortes N; Bergmann F; Schemmer P; Jäger D; Radeleff B; Schulze-Bergkamen H
Pancreatology; 2014; 14(6):546-9. PubMed ID: 25280592
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.
de Leede EM; Burgmans MC; Martini CH; Tijl FG; van Erkel AR; Vuyk J; Kapiteijn E; Verhoef C; van de Velde CJ; Vahrmeijer AL
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501370
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T
Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
